Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ January 28, 2023 ] TYR Sport Signs Prodigy Katie Grimes. Los Angeles Biotech News
  • [ January 27, 2023 ] Ayal Willner, MD, is recognized by Continental Who’s Who Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15(c) Announcement – Rule 15 Proposal to Horizon Equity Award Holders and Participants in the Horizon Employee Share Purchase Plan Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15 (c) Announcement – Horizon Therapeutics plc Los Angeles Biotech News
  • [ January 27, 2023 ] Research Technician I – Zymo Research – Irvine, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsBalt Receives IDE Approval From the FDA to Begin the STEM Trial

Balt Receives IDE Approval From the FDA to Begin the STEM Trial

May 15, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Balt Receives IDE Approval From the FDA to Begin the STEM Trial
IRVINE, Calif.--(BUSINESS WIRE)--Balt receives IDE approval from the FDA to begin the STEM Trial for the treatment of chronic Sub-Dural Hematoma (cSDH).

Click to view original post

Previous

FATHOMWERX Officially Announced as Tech Bridge for NavalX

Next

Cherry Thomas joins Caribou as SVP of clinical development; Artax locks in Joseph Lobacki as CEO

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered